The International Society for Cell & Gene Therapy (ISCT) celebrates the recent announcement of the U.S. Food and Drug Administration's (FDA) accelerated approval of Tecelra (afamitresgene autoleucel) for the treatment of adults with unresectable or metastatic synovial sarcoma who have...
The Rise of Asia Pacific: Learning From the Region’s Leaders and Innovators Organized by: ISCT Asia Regional Executive Committee Summary of Key Points from ISCT 2024 Vancouver Roundtable session on May 31, 8 am Moderator: Steve Oh, PhD - Independent Cell Therapy Leader, Singapore ...
Are you using prediction algorithms, machine learning (ML), or artificial intelligence (AI) in your work? Are you interested in finding out more about these terms and their applications? As part of a two-part initiative on AI and ML, The ISCT Process Development & Manufacturing Sub...
Wouter Van’t Hof, Contributing Editor Cleveland Cord Blood Center Cleveland OH, USA What’s in Your CGT Product? The shared responsibility of all of us cell and gene therapy developers involved with ISCT and with the ambition of bringing cell-based therapies to...
Vancouver, Canada, January 09, 2024 - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cell and gene therapy (CGT) into safe and effective...
ISCT Asia Regional Early Stage Professionals (ESP) Subcommittee Expanding the collaboration network to promote our clinical translation and successful services of cell and gene therapies Sudipto Bari, PhD 1 , Chaiyong Koaykul, PhD 2 Co-chairs ISCT Asia regional ESP...
ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies US federal judge ruling of significant concern, with widespread implications for cell and gene therapy sector as well as patient safety Vancouver, Canada, September 12, 2022 - ...
ISCT addresses manufacturing standardization, a critical issue constraining the CGT development pipeline Key insights published from ISCT 2022 Commercialization Signature Series Vancouver, Canada, September 8, 2022 - The International Society for Cell & Gene Therapy (ISCT...
ISCT & CMaT to roll out additional training programs following successful global launch of 'Workforce Development in Biomanufacturing' course The collaboration seeks to address the critical skilled labor shortage in the cell and gene therapy industry. Vancouver, Canada,...
ISCT marks bluebird bio’s landmark FDA approval a celebration for the CGT sector while calling industry to attention in the pursuit of patient access Vancouver, Canada, August 22, 2022 - The International Society for Cell & Gene Therapy (ISCT) , the global society of...